Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

  • Showing results for a modified search because your search retrieved no results.
1.

Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core.

Cairns NJ, Taylor-Reinwald L, Morris JC; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):274-9. doi: 10.1016/j.jalz.2010.03.012.

2.

Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN).

Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network.

Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.

3.

Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.

Franklin EE, Perrin RJ, Vincent B, Baxter M, Morris JC, Cairns NJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):815-22. doi: 10.1016/j.jalz.2015.05.010. Review.

PMID:
26194314
4.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L.

Neurology. 1991 Apr;41(4):479-86.

PMID:
2011243
5.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006. Review.

6.

Neuropathologic correlates of late-onset major depression.

Sweet RA, Hamilton RL, Butters MA, Mulsant BH, Pollock BG, Lewis DA, Lopez OL, DeKosky ST, Reynolds CF 3rd.

Neuropsychopharmacology. 2004 Dec;29(12):2242-50.

7.

Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience.

Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD.

Arch Pathol Lab Med. 1997 Jun;121(6):615-8.

PMID:
9199629
8.

[Neuropathology of mild cognitive impairment Alzheimer's disease].

Murayam S, Saito Y.

Rinsho Shinkeigaku. 2007 Nov;47(11):912-4. Japanese.

PMID:
18210833
9.

Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.

Serrano-Pozo A, Qian J, Monsell SE, Frosch MP, Betensky RA, Hyman BT.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1182-92. doi: 10.1097/NEN.0000000000000016.

10.

[Current topics about mild cognitive impairment (MCI)].

Yamamoto Y.

Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.

PMID:
21815470
11.

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

Sabbagh MN, Shah F, Reid RT, Sue L, Connor DJ, Peterson LK, Beach TG.

Arch Neurol. 2006 Dec;63(12):1771-6.

PMID:
17172618
12.

Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus.

Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, Sabbagh MN.

Alzheimers Dement. 2011 Sep;7(5):509-13. doi: 10.1016/j.jalz.2010.12.008. Epub 2011 Jul 1.

13.

Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):212-20. doi: 10.1016/j.jalz.2010.03.004. Review.

14.

Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.

Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL.

Arch Gen Psychiatry. 1998 Mar;55(3):205-11.

PMID:
9510214
15.

Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.

Iwatsubo T.

Alzheimers Dement. 2010 May;6(3):297-9. doi: 10.1016/j.jalz.2010.03.011.

PMID:
20451880
16.

Worldwide Alzheimer's disease neuroimaging initiative.

Carrillo MC, Bain LJ, Frisoni GB, Weiner MW.

Alzheimers Dement. 2012 Jul;8(4):337-42. doi: 10.1016/j.jalz.2012.04.007. Review.

PMID:
22748939
17.

"Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR.

Neurology. 2000 Aug 8;55(3):370-6.

PMID:
10932270
18.

Alzheimer's disease neuroimaging initiative in Europe.

Frisoni GB.

Alzheimers Dement. 2010 May;6(3):280-5. doi: 10.1016/j.jalz.2010.03.005.

PMID:
20451877
19.

Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.

Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR.

Neurobiol Aging. 2005 Mar;26(3):341-7.

PMID:
15639312
20.

The neuropathology of Alzheimer disease in African American and white individuals.

Wilkins CH, Grant EA, Schmitt SE, McKeel DW, Morris JC.

Arch Neurol. 2006 Jan;63(1):87-90.

PMID:
16401740
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk